SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials. Global Cardiol [Internet]. 2023 Nov. 23 [cited 2025 May 4];1(1). Available from: https://www.globalcardiology.info/site/article/view/2